
NanoViricides, Inc.
AMEX:NNVC
Overview | Financials
Company Name | NanoViricides, Inc. |
Symbol | NNVC |
Currency | USD |
Price | 1.1 |
Market Cap | 12,832,600 |
Dividend Yield | 0% |
52-week-range | 1 - 2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Anil R. Diwan Ph.D. |
Website | https://www.nanoviricides.com |
An error occurred while fetching data.
About NanoViricides, Inc.
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD